– Interview with Dr. Ian Larson, Senior Lecturer in Pharmaceutics and Formulation Science, Monash University

Genetic engineeringGenetic Engineering and BiotechnologyNanoparticlesNanotechnologyTechnology and Computational Biology
Previous articleP. vivax and P. knowlesi Genomes Decoded
Next articleEpiCept Wins EU Approval for AML Treatment